AHA reiterates support for most-favored nation drug price rule’s withdrawal
The AHA today restated its strong support for the Centers for Medicare & Medicaid Services’ withdrawal of its Most Favored Nation Model proposed rule. In January, the AHA questioned the proposal’s legality and structure, while expressing deep concerns for the extent to which patients would be negatively impacted by the policy.
Related News Articles
Perspective
Hospitals and health systems — and the women and men who work there — are the heart of health care. In good times like the birth of a child, or in bad…
Headline
The Centers for Medicare & Medicaid Aug. 15 announced it negotiated lower prices with drug makers for 10 high-cost, sole-source drugs, with the new prices…
Headline
The Senate Appropriations Committee Aug. 1 voted 25-3 to approve legislation that would provide $231.3 billion in funding for the departments of Labor, Health…
Headline
During the July 22 morning plenary session, Stacey Hughes, AHA’s executive vice president of government relations and public policy, moderated a panel with…
Headline
The Centers for Medicare & Medicaid Services July 16 released its final guidance on the Medicare Prescription Payment Plan which will begin next year. The…
Headline
The AHA July 15 commented to Sens. Sheldon Whitehouse, D-R.I., and Bill Cassidy, R-La., responding to a request for information based on the Pay PCPs Act,…